Phase I Study of Oral Lenalidomide in Patients With Refractory Metastatic Cancer
Journal of Clinical Pharmacology - United States
doi 10.1177/0091270009335001
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 1, 2009
Authors
Publisher
Wiley